TVF International has finalized a deal with Netflix for the UK and Ireland rights to the landmark documentary "The Ozempic Effect: Beyond the Waistline" (1x54). Originally commissioned by the CBC, the film is scheduled to launch on the streaming platform this Friday, February 27, 2026.
The documentary provides an in-depth investigation into the rise of the pharmaceutical product, tracing its development by Denmark’s Novo Nordisk to its current status as a global phenomenon.
The film explores the scientific breakthroughs behind the drug, alongside personal weight loss stories and the potential socio-economic impacts on industries such as travel, fashion, and food.
Initially launched at MIPCOM, TVF International has also secured sales for the title with several international broadcasters, including SBS in Australia, Movistar Plus+ in Spain, RTP in Portugal, RTV Slovenia, and HRT in Croatia.
TVF International Sells The Ozempic Effect Beyond The Waistline to Netflix for UK and Ireland
